Internal · Component Library

Data-Figure Components

Deterministic, code-rendered figures for evidence-graded articles. Every chart is real SVG computed from real numbers — never an image of a chart. Each figure carries an optional caption and a mandatory source line, and adapts to both themes.

1 · ComparisonTable

PeptideTypical doseHalf-lifePrimary useEvidence
BPC-157250–500 µg~4 hSoft-tissue & gut repair
TB-500 (Tβ4)2–2.5 mg~2–8 hTissue repair, angiogenesis
GHK-Cu1–2 mg~1 hSkin & wound healing
Thymosin α-11.6 mg~2 hImmune modulation
Semaglutide0.25–2.4 mg/wk~7 daysMetabolic / weight
Table 1 Common research peptides at a glance — dosing, kinetics, and the strength of human evidence behind each.

Source: Manufacturer PI sheets and peptide pharmacology reviews. Ranges are illustrative; several agents remain investigational.

2 · DosingChart

0 200 400 600 800 1000 µg Acute soft-tissue 400 Gut / GI protocol 500 Tendon / ligament 500 Systemic (research) 600
Figure 1 BPC-157 daily dosing by indication. Bars mark the commonly used dose; gold whiskers show the reported range.

Source: Illustrative clinical ranges. BPC-157 is investigational and not approved by the FDA or EMA.

3 · HalfLifeCurve

0 0.63 1.25 1.88 2.5 0246810 mg time (h) t½ · 50%
Figure 2 Modeled plasma clearance of a 2.5 mg TB-500 dose at a 2-hour half-life. Each half-life removes 50% of what remains.

Source: Deterministic model, C(t) = dose · 0.5^(t/t½). Thymosin β4 kinetics are illustrative and investigational.

4 · Timeline

  1. Screening & baseline labs Day 0

    Fibrinogen, lipid panel, Lp(a), coagulation, and viral serology before the first session.

  2. Venous access ~10 min

    Two peripheral lines are placed and regional anticoagulation is started.

  3. Plasma separation ~30 min

    Whole blood is separated into plasma and cellular components.

  4. Precipitation & filtration ~90 min

    Heparin-mediated precipitation removes LDL, Lp(a), and fibrinogen; plasma is filtered and reconstituted.

  5. Reinfusion & monitoring ~20 min

    Treated blood is returned to the patient while vitals are monitored.

  6. Follow-up review Week 1

    Repeat markers are drawn and the series cadence is scheduled.

Protocol A single H.E.L.P. apheresis session, start to finish.

Source: Klinik St. Georg H.E.L.P. apheresis protocol. Timings are approximate and vary by patient.

5 · EvidenceGrade

The four-step evidence ladder used across the site and inside ComparisonTable cells.

6 · StatCallout

Plasma half-life

≈ 2–8 hours

Reported elimination half-life range for thymosin β4 fragments.

Source: Peptide pharmacology reviews (illustrative).

Cleared per half-life

50%

Every half-life removes half of the drug still in circulation — the basis of the decay curve above.